Phase 2 Non-Alcoholic Fatty Liver Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 or older (both male and female)
- People who are willing to sign a consent form and agree to follow the study procedures and attend follow-up appointments
- People who have at least three out of five signs of metabolic problems: a large waist measurement (102 cm or more for men, 88 cm or more for women); low "good" cholesterol (HDL) or taking medication for it; high triglycerides (a type of fat in the blood) or taking medication for it; high blood pressure or taking medication for it; high fasting blood sugar or taking medication for it
- People with raised liver enzyme levels (between 1 and 4 times the normal upper limit), as shown by a blood test
- People with imaging results (ultrasound and a specific liver scan called FibroCAP) showing fat in the liver
Who may not be able to join:
- People who are pregnant or breastfeeding
- People with certain physical or mental health conditions (confirm with trial site)
- People with a Hepatitis C (HCV) infection
- People with a Hepatitis B (HBV) infection
- People with anaemia (low red blood cell levels)
- People with thrombocytopenia (low platelet levels in the blood)
- People with blood cancers
- People who drink alcohol above certain daily limits (more than 30g per day for men, more than 20g per day for women)
- People with kidney failure
- People with autoimmune hepatitis (a condition where the immune system attacks the liver)
- People with coeliac disease
- People with Wilson's disease (a genetic condition affecting copper levels)
- People with haemochromatosis (a genetic condition affecting iron levels)
- People currently taking certain medications, including tamoxifen, valproic acid, amiodarone, methotrexate, steroids, anticoagulants (blood thinners), antioxidant agents, or using a contraceptive coil (IUD) (confirm with trial site)
- People who regularly take medications that suppress the immune system or that can affect liver function
- People with an underactive or overactive thyroid
- People who have had bypass surgery (confirm with trial site)
- People receiving nutrition directly into their bloodstream (Total Parenteral Nutrition)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +201112720114
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in liver steatosis degree
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.